Skip to content
Open access

Protective Effects of Nebivolol Against Cisplatin-Induced Nephrotoxicity: An Experimental Study

Aug 2026 · University of Science and Technology Journal for Medical Sciences · 0 citations · 27 references

TL;DR

Nebivolol can ameliorate CIN in rats, as demonstrated by improvements in several renal functional, oxidative-stress, inflammatory, and histopathological outcomes, which support the nephroprotective potential of nebivolol but warrant confirmation in further preclinical studies.

Abstract

Background: Cisplatin is an effective and commonly used anticancer drug, but its therapeutic application is constrained by its potential to cause kidney injury. This experimental study investigated nebivolol protective effects, which is a third-generation selective β1-adrenoceptor blocker with additional β3-adrenoceptor agonistic activity, against cisplatin-induced nephrotoxicity (CIN) in rats. Methods: Twenty-one male Wistar rats were randomly allocated to three groups (n = 7 per group): control, cisplatin, and cisplatin plus nebivolol. Nebivolol (10 mg/kg/day, orally) was administered for 28 days, and cisplatin (6 mg/kg, intraperitoneally) was administered once on day 24. Renal function was assessed using serum and urine creatinine, blood urea nitrogen (BUN), serum urea, serum total protein, and creatinine clearance. Serum potassium and sodium concentrations were also measured. Renal oxidative stress was assessed using reduced glutathione (GSH), superoxide dismutase (SOD), and malondialdehyde (MDA). Serum tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) were measured as inflammatory markers. Hematoxylin and eosin (H&E) and periodic acid–Schiff (PAS) staining of kidney tissue sections were used to assess the histopathological changes. Results: Body and relative kidney weights showed no significant between-group differences. Cisplatin induced marked renal dysfunction, inflammation, oxidative stress, electrolyte disturbances, and histopathological injury. Compared with cisplatin alone, nebivolol significantly reduced serum creatinine, urea, BUN, IL-6, and TNF-α concentrations and renal MDA levels, while increasing urine creatinine, serum total protein, renal GSH, and SOD activity. Creatinine clearance was higher after nebivolol coadministration than after cisplatin alone, but the difference was not statistically significant (P = 0.077). Nebivolol also attenuated tubular necrosis and inflammatory-cell infiltration and improved tubular, glomerular, and brush-border morphology. However, its effects on electrolytes were incomplete: serum potassium increased without reaching statistical significance compared with the cisplatin group, whereas sodium decreased further. Conclusion: Nebivolol can ameliorate CIN in rats, as demonstrated by improvements in several renal functional, oxidative-stress, inflammatory, and histopathological outcomes. These findings support the nephroprotective potential of nebivolol but warrant confirmation in further preclinical studies.

Read PDF

Similar papers

Aug 2026

Nephroprotective effect of vitamin E and sodium selenite against azithromycin-induced renal toxicity in a rat model: attenuation of oxidative stress, inflammation, and apoptosis.

Combined therapeutic potential in attenuating AZM-induced renal toxicity and co-administration of vitamin E and sodium selenite confers marked nephroprotection mediated through antioxidant and anti-apoptotic actions are suggested.

Marwan A. Ibrahim, Ibrahim M. Ibrahim Laila, A. M. Algohary et al. · 0 citations
Open access Aug 2026

Protective Effects of Luteolin Against Cisplatin‐Induced Hepatic and Renal Toxicity: Biochemical and Cellular Evidence

It is suggested that Luteolin may represent a promising adjunctive candidate for reducing Cisplatin‐associated toxicity while improving therapeutic responsiveness and in vitro antiproliferative activity.

Ö. Temiz, Suna Kızılyıldırım, Tuba Ozdemir-Sanci et al. · 0 citations
Open access Sep 2026

Hepato-renal toxicity of concurrent metronidazole and azithromycin administration in mice: biochemical, oxidative stress, and histopathological evidence

Medical professionals in both human and animal healthcare frequently use antibiotic therapy concurrently, but researchers have not fully studied the potential adverse effects of combined antibiotic therapy. Therefore, the aim of this study was to investigate the effects of repeated administration of metronidazole and a...

Shahad I. Al Nuaimi, Nabaa Kh. Abdullah, Tamara K. Al-Najmawi et al. · 0 citations
Open access Sep 2026

Protective Effects of Ethyl Pyruvate and Rutin Hydrate Against Colistin-Induced Nephrotoxicity in Rats

These findings suggest that EP and RH may be promising adjuvant agents against colistin-induced nephrotoxicity, and showed numerically greater protection across most assessed parameters, although an overall advantage over single-agent co-treatment was not statistically established.

Mehmet Nuri Gördük, İ. Kelle, M. Erdinc et al. · 0 citations
Open access Sep 2026

Nephroprotective Effects of Carvedilol and Sodium Copper Chlorophyllin in Glycerol-Induced Acute Kidney Injury in Female Rats

Renal impairment was considerably reduced by treatment with carvedilol or SCC, while the combination of both drugs produced a particularly strong protective effect by normalising biochemical variables and reducing oxidative stress more effectively than either monotherapy.

Shahad Ali Naeem, A. Abdullah · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.